𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein

✍ Scribed by Athanasios Anagnostopoulos; Eleni Galani; Dimitra Gika; Danai Sotou; Aikaterini Evangelopoulou; Meletios Athanasios Dimopoulos


Publisher
Springer
Year
2004
Tongue
English
Weight
64 KB
Volume
83
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cancer risk in patients with monoclonal
✍ Gregersen, Henrik; MellemkjοΏ½r, Lene; Salling Ibsen, Jenna; SοΏ½rensen, Henrik Toft πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 2 views

To assess the cancer risk of monoclonal gammopathy of undetermined significance (MGUS) we identified 1229 cases of MGUS in the period 1978 to 1993. Data on cancer occurrence in the MGUS cohort were obtained from the Danish Cancer Registry. The expected numbers of cancer cases were calculated from ag

Clinical features, evaluation, and treat
✍ Kenneth C. Gorson πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 2 views

A number of common disorders of the peripheral nervous system are closely linked to a monoclonal gammopathy. In a minority of patients, the neuropathy represents the sentinel feature of a malignant plasma cell dyscrasia, such as multiple myeloma or its osteosclerotic variant, Waldenstrom's disease,

Patterns of monoclonal immunoglobulins a
✍ Brendan M. Weiss; Alex Minter; Jude Abadie; Robin Howard; Joao Ascencao; Geraldi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

## Abstract Monoclonal gammopathy of undetermined significance (MGUS), the precursor to multiple myeloma, is more common in blacks than whites. The serum free light chain (sFLC) assay is an important prognostic test in MGUS, but no study has evaluated sFLC levels and ratios in black MGUS patients.